Dr Mads Krogsgaard Thomsen speaking to international media at the Novo Nordisk Favrholm campus in Denmark. He observed that once countries become obese, there is a lag time of about 10 years before the resultant increase in diabetes. - Novo Nordisk
Danish pharmaceutical company Novo Nordisk tackles both obesity and diabetes in their current drug pipeline.
Being overweight or obese has long been known to be a risk factor for type 2 diabetes.
Already a subscriber? Log in
Save 30% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
